These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28389699)

  • 1. Ion channelopathies and migraine pathogenesis.
    Albury CL; Stuart S; Haupt LM; Griffiths LR
    Mol Genet Genomics; 2017 Aug; 292(4):729-739. PubMed ID: 28389699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine: Role of the TRESK two-pore potassium channel.
    Lafrenière RG; Rouleau GA
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1533-6. PubMed ID: 21855646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNK18 (TRESK) genetic variants in Italian patients with migraine.
    Rainero I; Rubino E; Gallone S; Zavarise P; Carli D; Boschi S; Fenoglio P; Savi L; Gentile S; Benna P; Pinessi L; Dalla Volta G
    Headache; 2014 Oct; 54(9):1515-22. PubMed ID: 25324165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of 3 common polymorphisms in the KCNK18 gene in an Australian Migraine case-control cohort.
    Maher BH; Taylor M; Stuart S; Okolicsanyi RK; Roy B; Sutherland HG; Haupt LM; Griffiths LR
    Gene; 2013 Oct; 528(2):343-6. PubMed ID: 23911303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two-pore-domain potassium channels and molecular mechanisms underlying migraine].
    Royal P; Ávalos Prado P; Wdziekonski B; Sandoz G
    Biol Aujourdhui; 2019; 213(1-2):51-57. PubMed ID: 31274103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel genes involved in migraine.
    Lafrenière RG; Rouleau GA
    Headache; 2012 Oct; 52 Suppl 2():107-10. PubMed ID: 23030542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura.
    Lafrenière RG; Cader MZ; Poulin JF; Andres-Enguix I; Simoneau M; Gupta N; Boisvert K; Lafrenière F; McLaughlan S; Dubé MP; Marcinkiewicz MM; Ramagopalan S; Ansorge O; Brais B; Sequeiros J; Pereira-Monteiro JM; Griffiths LR; Tucker SJ; Ebers G; Rouleau GA
    Nat Med; 2010 Oct; 16(10):1157-60. PubMed ID: 20871611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered functional properties of a missense variant in the TRESK K
    Imbrici P; Nematian-Ardestani E; Hasan S; Pessia M; Tucker SJ; D'Adamo MC
    Pflugers Arch; 2020 Jul; 472(7):923-930. PubMed ID: 32394190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genes.
    Domitrz I; Kosiorek M; Żekanowski C; Kamińska A
    Hum Genomics; 2016 Jan; 10():3. PubMed ID: 26747084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of variants in genes implicated in rare familial migraine syndromes and their association with migraine in 200,000 exome-sequenced UK Biobank participants.
    Markel KA; Curtis D
    Ann Hum Genet; 2022 Nov; 86(6):353-360. PubMed ID: 36044383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A causal role for TRESK loss of function in migraine mechanisms.
    Pettingill P; Weir GA; Wei T; Wu Y; Flower G; Lalic T; Handel A; Duggal G; Chintawar S; Cheung J; Arunasalam K; Couper E; Haupt LM; Griffiths LR; Bassett A; Cowley SA; Cader MZ
    Brain; 2019 Dec; 142(12):3852-3867. PubMed ID: 31742594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic neurological channelopathies: molecular genetics and clinical phenotypes.
    Spillane J; Kullmann DM; Hanna MG
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):37-48. PubMed ID: 26558925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine: Genetic Variants and Clinical Phenotypes.
    Rainero I; Vacca A; Govone F; Gai A; Pinessi L; Rubino E
    Curr Med Chem; 2019; 26(34):6207-6221. PubMed ID: 30027842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is migraine a neuronal channelopothy?].
    Kwieciński H
    Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S61-4. PubMed ID: 16419572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18.
    Sehgal SA; Hassan M; Rashid S
    Drug Des Devel Ther; 2014; 8():571-81. PubMed ID: 24899801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Background K
    Andres-Bilbe A; Castellanos A; Pujol-Coma A; Callejo G; Comes N; Gasull X
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Channelopathies: a genetic explanation of migraine and other paroxysmal neurologic disorders].
    Terwindt GM; Ophoff RA; Haan J; Frants RR; Ferrari MD
    Ned Tijdschr Geneeskd; 1998 May; 142(18):1015-9. PubMed ID: 9623202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of migraine].
    Ducros A
    Rev Neurol (Paris); 2013 May; 169(5):360-71. PubMed ID: 23618705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly polymorphic poly-glutamine stretch in the potassium channel KCNN3 in migraine.
    Mössner R; Weichselbaum A; Marziniak M; Freitag CM; Lesch KP; Sommer C; Meyer J
    Headache; 2005 Feb; 45(2):132-6. PubMed ID: 15705118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ion channels and mechanisms of inherited disease transmission causing migraine].
    Royal P; Sandoz G
    Med Sci (Paris); 2019; 35(8-9):608-610. PubMed ID: 31539490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.